Skip to main content
. 2012 Sep 27;4(3):e35. doi: 10.4081/rt.2012.e35

Table 3. Rare Cancer Network studies of head and neck cancers.

Head and neck Author Year Cases Results
Outcome and prognostic factors in orbital lymphoma Martinet9 2003 90 Moderate to low-dose RT (<34 Gy) alone controls primary orbital lymphoma with low morbidity
Abstract: Outcomes and prognostic factors in primary intraocular lymphoma Mak10 2007 20 5-year overall, disease free survival, and local control rates of 55,39,72%. high rate of CNS recurrence (51% at 5-years). Vitreous involvement=worse prognosis. CNS prophylaxis and more aggressive therapies need to be considered
Radiotherapy in the treatment of mucosal melanoma of the upper aerodisgestive tract Mirimanoff11 2006 74 Local control at 3 years- 57% with surgery and 71% after surgery and RT
Treatment results of 165 pediatric patients with non-metastatic nasopharyngeal carcinoma Ozyar12 2006 165 5-year overall survival 77.4%, disease free-68.8%. Combined RT and chemotherapy was optimal treatment
Outcome and prognostic factors in olfactory neuroblastoma Ozsahin13 2010 77 5 year survival: overall- 64%, disease free- 57, locoregional-62, local control- 70. Surgery and post-op RT (>53Gy) had best outcome. Concomitant chemo+/−higher dose RT should be prospectively investigated
Primary mucosa-associated lymphoid tissue lymphoma of the salivary glands Anacak14 2010 63 5 year disease free, disease specific, and overall survival- 54.4,93.2,81.7%. Recurrences may occur in up to 35% of patients at 5 years, survival not affected. RT only modality that improved disease- free survival